AGEING RES REV 润色咨询

AGEING RESEARCH REVIEWS

出版年份：2002 年文章数：1191 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：2.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2022-07-11 ms6000002054670522

    with aditor一般要多久呀

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2022-04-25 Michael scofield123

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向：衰老
    经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2022-02-03 120b32b6m98(暂无昵称)

    想问一下大家，投这个杂志要钱吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2019-11-03 146b0e36m08暂无昵称

    什么方向啊 imp_winner01072 2019-10-22 发表::
    今天终于接收了，mark    imp_winner01072 2019-10-22 00:00:00 发表:
    今天终于接收了，mark

    imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2015-12-20 ms7715413884926041

    审稿速度:1.0
    经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2015-04-30 YuanW

    课题组一直在研究衰老，觉得应该跟这杂志领域相符。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2014-08-17 匿名用户

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写.

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2014-07-23 匿名用户

    审稿速度:2.0
    经验分享：在老年医学研究中，是最具权威性的。
    在科学院一区杂志中，还不是极难的。
    每年都有中国学者的文章，建议一试。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：衰老<br>经验分享：一审64天； 二审13天； 三审6天； 两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579275, encodeId=8fdd5e92752e, content=什么方向啊 <span class="quote">imp_winner01072 2019-10-22 发表::<br>今天终于接收了，mark</span><span class="quote">imp_winner01072 2019-10-22 00:00:00 发表:<br>今天终于接收了，mark</span>, beContent=imp_winner01072 2019-10-22 发表:: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=417c5158909, createdName=146b0e36m08暂无昵称, createdTime=Sun Nov 03 00:00:00 CST 2019, time=2019-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831401, encodeId=8da5831401f3, content=审稿速度:1.0<br>经验分享：很好的期刊，但要求稿件质量比较高，审稿速度比较快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd305413961, createdName=ms7715413884926041, createdTime=Sun Dec 20 20:32:25 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511553, encodeId=ecf051155329, content=课题组一直在研究衰老，觉得应该跟这杂志领域相符。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5b81617898, createdName=YuanW, createdTime=Thu Apr 30 08:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505393, encodeId=59a95053932f, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：不光要包含这个领域的前沿工作，而且最好还要包含自己的近期工作，所以导师要动手写., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 19:18:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504270, encodeId=16595042e019, content=审稿速度:2.0<br>经验分享：在老年医学研究中，是最具权威性的。 <br> 在科学院一区杂志中，还不是极难的。 <br> 每年都有中国学者的文章，建议一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 23 19:28:00 CST 2014, time=2014-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485323, encodeId=b0424853233d, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=HYL, createdTime=Tue Nov 08 14:55:00 CST 2011, time=2011-11-08, status=1, ipAttribution=)]
    2011-11-08 HYL

    审稿速度:3.0 | 投稿命中率:5.0
    经验分享：Ageing Research Reviews改杂志为季刊，年发表文章为54篇，所以命中率很低。本人刚中一篇，感觉审稿速度还是可以的。应该说是Ageing 方面比较权威的杂志吧。

    0

共72条页码: 3/8页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分